Loading clinical trials...
Loading clinical trials...
Early diagnosis of cardiac amyloidosis (CA) is crucial because of the poor overall survival, high mortality and the need for early therapy including new treatment possibilities for transthyretin amylo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Essen
NCT06427304 · Cardiac Amyloidosis
NCT07306949 · Transthyretin-type Cardiac Amyloidosis
NCT06096675 · Cardiac Amyloidosis
NCT06894290 · Cardiac Amyloidosis
NCT05797857 · Amyloid Cardiomyopathy, Transthyretin Cardiac Amyloidosis
University Hospital Essen
Essen, North Rhine-Westphalia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions